Authors | Country | Setting | Study period | Total number of patients randomized | Patients’ conditions | No. of study arms | Interventions | Comparisons | Outcomes |
---|---|---|---|---|---|---|---|---|---|
Cevik et al. [18] | Turkey | Single-center, open-label | September 2007 to May 2008 | 34 | Patients requiring MV and sedation in the ICU | 2 | Fentanyl-midazolam regimen | Remifentanil-midazolam regimen | • Hemodynamic parameters • Analgesics and sedative dosage • Mean MV timea • Mean time to ICU dischargea • Organ dysfunction • Adverse effecta |
Karabinis et al. [19] | Six countries in Europe (4 hospitals in Greece, 4 in Spain, 3 in Belgium, 3 in The Netherlands, 2 in Germany, 1 in Austria) | Multi-center, open-label | Not stated (published in 2004) | 161 | Acute, severe neurological insult or injury, or patients who had undergone elective or emergency neurosurgery | 3 | Hypnotic-based treatment (fentanyl) | Remifentanil-based treatment | • Median time on MVa • Extubation process • Extubation to ICU dischargea • Serious adverse eventsa • Drug-related serious adverse events • Mortalitya |
Liu et al. [20] | China | Single-center, double-blind | September 2014 to January 2015 | 105 | MV anticipated for > 24 h | 3 | Fentanyl | Remifentanil | • 28-day mortalitya • Duration of MVa • Length of the ICU staya • Deliriuma • Duration of delirium • Weaning time |
Muellejans et al. [21] | Five countries, 21 centers (4 centers in Belgium, 8 in Germany, 1 in the Netherlands, 4 in Spain, 4 in the UK) | Multi-center, double-blind | Not stated (published in 2004) | 152 | MV for a further 12 to 72 h | 2 | Fentanyl | Remifentanil | • Extubation process – extubationa • Extubation – ICU discharge • Drug start—ICU dischargea • Adverse events • Drug-related adverse events • MAP < 50 mmHg • HR < 50 beats/min • Severe adverse eventsa |
Muellejans et al. [22] | Germany | Single-center, open-label | Not stated (published in 2006) | 80 | MV for > 12 h | 2 | Hypnotic-based sedation with midazolam/fentanyl | Remifentanil-based analgesia and sedation with propofol | • Any adverse event • Any serious adverse eventa • Deliriuma • Time from arrival in the ICU to extubationa • Time from arrival in the ICU to eligible ICU dischargea • Overall costs |
Oliver et al. [23] | United States | Single-center, observer-blind | Not stated (published in 2011) | 113 | Scheduled elective cardiac surgery | 3 | Fentanyl and propofol | Morphine and propofol | • Time to extubationa • First response time • Length of the ICU staya • Length of the hospital stay • ICU direct medical costs |
Spies et al. [24] | Germany | Two-center, double-blind | December 2005 to June 2008 | 60 | MV for > 24 h | 2 | Fentanyl | Remifentanil | • Proportion of patients who obtained the target analgesia score • Duration of MVa • Duration of the ICU staya • Duration of the hospital stay • Deliriuma |